穴位按压联合六字诀气功对重型新型冠状病毒肺炎患者肺功能和生活质量影响的随机对照试验研究方案
本研究为平行设计、两臂、分析者盲的随机对照试验,计划纳入128例20至80岁重型COVID-19患者,按1:1随机分配至指南治疗组或指南治疗联合中医康复(穴位按压联合六字诀气功)组。主要结局为改良医学研究委员会呼吸困难量表,次要结局包括日常生活活动Barthel指数、患者健康问卷-9和呼吸道症状量表,在治疗前、住院第7天和出院日评估。
要点
- 穴位按压联合六字诀气功作为重型COVID-19的辅助治疗,每日两次,从入院持续至出院。
- 主要结局采用改良医学研究委员会呼吸困难量表评估。
- 次要结局包括日常生活活动Barthel指数、患者健康问卷-9和呼吸道症状量表。
核心结论
- 该试验旨在为穴位按压联合六字诀气功治疗重型COVID-19提供高质量证据。
研究设计与样本
- 平行设计、两臂、分析者盲的随机对照试验。
- 计划招募128例20至80岁COVID-19患者,按1:1随机分配至指南治疗组和指南治疗联合中医康复组。
关键数值与推荐
- 干预组在常规治疗基础上每日两次进行穴位按压和六字诀气功锻炼,从入院持续至出院。
- 主要结局为改良医学研究委员会呼吸困难量表。
- 次要结局包括日常生活活动Barthel指数、患者健康问卷-9和呼吸道症状量表。
- 评估时间点为治疗前、住院第7天和出院日。
- 不良事件将被记录用于安全性评价。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: In December 2019, pneumonia associated with the 2019 novel coronavirus (COVID-19) emerged in Wuhan, China. The number of cases has increased rapidly. Patients with severe disease have a poor prognosis, and there are no effective therapies for COVID-19. Only rapid advice guidelines for symptomatic supportive care have been used. A traditional Chinese medicine rehabilitation (TCMR) program consisting of acupressure therapy and Liu Zi Jue Qigong can be used as a complementary therapy for COVID-19. Hence, we designed a randomized trial to evaluate the efficacy and advantages of TCMR for treating patients with severe COVID-19. METHODS/DESIGN: This is a parallel-design, two-arm, analyst assessor-blinded, randomized controlled trial. A total of 128 patients with COVID-19 aged from 20 to 80 years will be recruited and assigned randomly into a guideline therapy group and a guideline therapy plus TCMR group at a 1:1 ratio. Patients in both groups will receive guideline therapy. The patients in the intervention group will perform acupressure therapy and Liu Zi Jue Qigong exercises in addition to conventional treatments twice a day and will be persistent from admission to discharge. The primary outcome will be measured with the Modified Medical Research Council Dyspnea Scale, and the secondary outcomes will include the Activities of Daily Living Barthel Index Scale, Patient Health Questionnaire-9 Scale, and the Respiratory Symptoms Scale. The assessments of the clinical scales will be performed at three points (before treatment, the 7th day during hospitalization, and the discharge day). Adverse events will be noted and recorded for the safety evaluation. DISCUSSION: This trial will provide high-quality evidence of the value of TCMR, which consists of acupressure therapy and Liu Zi Jue Qigong exercises, for treating patients with severe COVID-19. TRIAL REGISTRATION: Chinese Clinical Trial Registry ChiCTR2000029994 . Registered on 18 February 2020.
引用
- Zhang S, Zhu Q, Zhan C, et al. Acupressure therapy and Liu Zi Jue Qigong for pulmonary function and quality of life in patients with severe novel coronavirus pneumonia (COVID-19): a study protocol for a randomized controlled trial. Trials. 2020. PMID: 32854761. doi:10.1186/s13063-020-04693-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。